Remedium Research · For in-vitro laboratory research only. Not for human or veterinary use.Research Use Only
TL;DR — Verdict

The retatrutide 40mg vial is the route for labs that want more total material per unit and custom reconstitution control, not the easiest workflow. Live pricing runs from AED 1,200 single to AED 1,000 per vial at the 5-pack tier, same-day Dubai dispatch is stated on the product page, and the material ships as a lyophilised 40mg vial that requires bacteriostatic water. The trade-off is honesty: unlike the 20mg and flagship pen routes, the current 40mg page notes that batch-specific public COA documentation will be added as it becomes available. If the protocol values sealed click precision over reconstitution flexibility, the 20mg pen guide or 30mg Dubai guide is the cleaner fit.

Open 40mg Product Page → Open Reconstitution Guide → Compare to 20mg Pen →

What the 40mg Vial Is For

The 40mg route is a lyophilised retatrutide vial, not a click-based device. That means the molecule is the same triple-agonist compound discussed across the retatrutide literature, but the day-to-day workflow is different: the lab must choose a solvent, set the concentration, manage cold storage after reconstitution, and control for handling contamination.

That extra work is the reason the 40mg vial exists at all. Some labs prefer the vial because it carries more total material per unit and allows custom reconstitution ratios rather than fixed click increments. Others will prefer the pen routes precisely because they remove those variables.

Why Researchers Pick the Vial Instead of a Pen

Format Total Load Main Trade-Off Best Fit
20mg Pen 20mg / 200 clicks Smallest sealed route with public batch proof Labs that want simple click-based handling
30mg Pen 30mg / 300 clicks Most total clicks in the sealed-device format Flagship pen route for Dubai researchers
40mg Vial 40mg lyophilised Requires bacteriostatic water and concentration control Labs that want higher total mass and custom ratios

The simplest rule is this: if the workflow benefits from predefined, mechanical increments, use a pen. If it benefits from choosing the concentration deliberately and extracting more total mass from each unit, the vial becomes more attractive.

40MG VIAL

Lyophilised 40mg retatrutide vial — custom reconstitution workflow, cold-chain dispatch, Dubai stock.

Open 40mg Product Page →

Reconstitution, Storage & Handling Burden

The product page states clearly that bacteriostatic water is required and not included. That makes reconstitution the central practical question on this route. A vial workflow gives more control, but it also introduces more places to make mistakes: incorrect solvent volume, unstable concentration assumptions, or avoidable exposure during repeated access.

For that reason, the 40mg route is strongest in labs that already use standard peptide reconstitution protocols. Researchers who do not need that flexibility are usually better served by a sealed pen. The wider stability logic is covered in the peptide stability and storage guide.

COA Expectations & Sourcing Honesty

The most important detail on the current 40mg page is not a marketing claim. It is the explicit note that the ProPeptide line ships under the site’s cold-chain and research-use protocols, but that batch-specific COA documentation will be added to the public library as it becomes available.

That means the 40mg route should be treated differently from the 20mg pen and the 30mg flagship route, both of which already have public batch-linked proof. Researchers who require published lot-level verification before choosing a format should keep that distinction in view.

Pricing, Cost Per mg & Dispatch Timing

The current live price ladder for the 40mg vial is:

On a pure per-milligram basis, the vial is obviously cheaper than the pen routes. What the lab is paying for in the pen formats is not raw mass alone, but sealed-device convenience, simplified handling, and published route-specific proof where available.

The product page also states same-day Dubai dispatch when ordered before 4 PM and next-day other-emirates dispatch when ordered before 12 PM, under a 2–8°C cold-chain route. For the wider UAE context, see Retatrutide UAE.

What is the retatrutide 40mg vial route?

The 40mg route is a lyophilised retatrutide research format designed for labs that are comfortable with bacteriostatic-water reconstitution and custom concentration math.

What are the current AED pricing tiers?

Current live pricing is AED 1,200 for one vial, AED 3,300 for a 3-pack, and AED 5,000 for a 5-pack. That works out to AED 30/mg, AED 27.5/mg, and AED 25/mg respectively.

Does the 40mg vial require bacteriostatic water?

Yes. The vial is lyophilised and requires a separate reconstitution step, which is why it suits labs that already use peptide-mixing workflows.

Is there a public batch-specific COA for the 40mg vial yet?

The current product page says batch-specific COA documentation will be added to the public library as it becomes available. Researchers who need published batch proof today should compare against the 20mg or 30mg pen routes.

How does the 40mg vial differ from the pen formats?

The vial offers more total material and flexible concentration ratios, but it adds mixing, contamination control, and storage complexity. The pens are sealed and mechanically dosed.

Is the 40mg vial available in Dubai for research use only?

Yes. The page is framed for in-vitro laboratory research under UAE MoHAP Circular 17/2022 and is not positioned as an approved human or veterinary product.

How We Evaluated This Guide

This guide uses the live 40mg vial specifications, the public site language around cold-chain dispatch and COA availability, published retatrutide trial literature, and the repo’s established UAE research-use framing. The goal was to separate what is proven today from what is still pending public documentation. Read our editorial policy →

NH
About the Author

Research Director, Remy Peptides

Dr. Haroun reviews peptide handling, analytical proof standards, and evidence framing across the Remy research library.

About Dr. Haroun →
References & Citations
  1. Jastreboff AM, et al. Triple–Hormone-Receptor Agonist Retatrutide for Obesity. N Engl J Med. 2023;389(6):514–526.
  2. Coskun T, et al. LY3437943, a novel triple GIP/GLP-1/glucagon receptor agonist for glycaemic control and weight loss. Lancet. 2022;400(10366):1869–1881.
  3. Remy Peptides. Retatrutide 40mg vial product page.
  4. Remy Peptides. Bacteriostatic water guide and peptide stability guide.
  5. UAE Ministry of Health and Prevention. Circular 17/2022: regulatory framing for research materials.
40MG VIAL

Retatrutide 40 mg Vial

Lyophilised 40mg route, same-day Dubai dispatch, and flexible reconstitution for labs that need higher total load per unit.

Open 40mg Product Page →